Status:
COMPLETED
Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Biliary Colic
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study was performed to evaluate the role of BIS monitored sedation in reducing the dose of propofol and to know the effectiveness of pre-procedure administration of intravenous diclofenac sodium ...
Detailed Description
It was a single-center open-labeled Prospective Randomized study. After approval of the study by the institutional ethical committee \& obtaining written informed consent, 90 patients scheduled for ER...
Eligibility Criteria
Inclusion
- Age between 18-65 yrs
- ASA I \& II
Exclusion
- Age \< 18 yrs \& \> 65 yrs
- ASA III \& IV patients
- Chronic Liver Disease
- Pregnant patients
- Patients with a history of (H/O) Drug abuse
- Patients refusing consent
- H/o Acute kidney injury
- H/o allergy to propofol / lidocaine/ NSAIDS
- Post liver transplant patients
- Patients with h/o egg allergy
Key Trial Info
Start Date :
September 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04860167
Start Date
September 10 2018
End Date
November 14 2019
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaurav Sindwani
New Delhi, National Capital Territory of Delhi, India, 110060